Teacher Retirement System of Texas Sells 53,554 Shares of Orthofix Medical Inc. (NASDAQ:OFIX)

Teacher Retirement System of Texas trimmed its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 39.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 81,455 shares of the medical device company's stock after selling 53,554 shares during the period. Teacher Retirement System of Texas owned approximately 0.21% of Orthofix Medical worth $1,329,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Kirr Marbach & Co. LLC IN boosted its holdings in shares of Orthofix Medical by 29.5% during the 1st quarter. Kirr Marbach & Co. LLC IN now owns 39,462 shares of the medical device company's stock worth $644,000 after buying an additional 9,000 shares in the last quarter. Assenagon Asset Management S.A. raised its position in shares of Orthofix Medical by 421.1% during the first quarter. Assenagon Asset Management S.A. now owns 72,226 shares of the medical device company's stock worth $1,178,000 after purchasing an additional 58,366 shares during the period. GAMMA Investing LLC raised its position in shares of Orthofix Medical by 1,585.1% during the first quarter. GAMMA Investing LLC now owns 22,867 shares of the medical device company's stock worth $373,000 after purchasing an additional 21,510 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Orthofix Medical by 14.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 71,371 shares of the medical device company's stock worth $1,246,000 after purchasing an additional 8,772 shares during the period. Finally, Soleus Capital Management L.P. raised its position in shares of Orthofix Medical by 13.1% during the fourth quarter. Soleus Capital Management L.P. now owns 686,374 shares of the medical device company's stock worth $11,984,000 after purchasing an additional 79,441 shares during the period. 89.76% of the stock is currently owned by institutional investors.

Insider Activity at Orthofix Medical

In other Orthofix Medical news, major shareholder Engine Capital Management, Lp bought 100,000 shares of the firm's stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average cost of $12.31 per share, with a total value of $1,231,000.00. Following the transaction, the insider directly owned 3,544,807 shares in the company, valued at $43,636,574.17. This trade represents a 2.90% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Aviva Mcpherron sold 3,728 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total value of $39,181.28. Following the sale, the insider directly owned 46,322 shares of the company's stock, valued at approximately $486,844.22. This represents a 7.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders purchased 113,500 shares of company stock valued at $1,394,858. 1.30% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on OFIX. Wall Street Zen lowered Orthofix Medical from a "hold" rating to a "sell" rating in a research report on Friday, June 27th. Barrington Research raised Orthofix Medical to a "strong-buy" rating and set a $16.00 target price on the stock in a research report on Monday, June 23rd. Finally, JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a research report on Friday, June 6th. One analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.

Orthofix Medical Stock Down 0.7%

NASDAQ OFIX traded down $0.07 on Wednesday, reaching $10.69. The company had a trading volume of 304,013 shares, compared to its average volume of 289,270. The stock has a market capitalization of $418.83 million, a P/E ratio of -2.90 and a beta of 0.80. The company's fifty day moving average is $11.26 and its 200 day moving average is $14.67. Orthofix Medical Inc. has a 52-week low of $10.24 and a 52-week high of $20.73. The company has a quick ratio of 1.50, a current ratio of 2.71 and a debt-to-equity ratio of 0.38.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.